EUVIMEDEUVIMED entdecken
Crossref

Glucosylated Nanovaccines for Dendritic Cell-Targeted Antigen Delivery and Amplified Cancer Immunotherapy

Jing Liu, Yongsheng Cui, Horacio Cabral iD, Aiping Tong, Qiang Yue, Lihong Zhao, Xun Sun, Peng Mi iD

ACS Nano · 17.09.2024 · 18 (37) · 25826-25840

DOI: 10.1021/acsnano.4c09053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 28.08.2024. Verfasst von Jing Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, State Key Laboratory of Biotherapy and Huaxi MR Research Center (HMRRC), West China Hospital, Sichuan University, Chengdu, S…. Hauptthemen laut MEDLINE: Dendritic Cells, Immunotherapy, Cancer Vaccines, Mice, Inbred C57BL. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: West China Hospital, Sichuan University, National Key Research and Development Program of China, Science and Technology Department of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsImmunotherapyCancer VaccinesMice, Inbred C57BLAnimalsMiceOvalbuminNanoparticlesAntigens, NeoplasmFemaleAntigen PresentationCell Line, TumorHumansNanovaccines

Stichwörter der Autor:innen

antigen deliveryimmunotherapynanocarriersneoantigentargeting dendritic cellstumorvaccine

Substanzen

Cancer VaccinesOvalbuminAntigens, NeoplasmNanovaccines

Autor:innen und Institutionen

  • Department of Radiology, State Key Laboratory of Biotherapy and Huaxi MR Research Center (HMRRC), West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
  • Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
  • Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Key Laboratory of Drug Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.

ORCID-Profile: Horacio Cabral, Peng Mi

Förderung

  • West China Hospital, Sichuan University
  • National Key Research and Development Program of China
  • Science and Technology Department of Sichuan Province
  • National Natural Science Foundation of China

Zitieren

APA

Liu, J., Cui, Y., Cabral, H., Tong, A., Yue, Q., Zhao, L., Sun, X., & Mi, P. (2024). Glucosylated Nanovaccines for Dendritic Cell-Targeted Antigen Delivery and Amplified Cancer Immunotherapy. ACS Nano, 18(37), 25826-25840. https://doi.org/10.1021/acsnano.4c09053

Vancouver

Liu J, Cui Y, Cabral H, Tong A, Yue Q, Zhao L, et al. Glucosylated Nanovaccines for Dendritic Cell-Targeted Antigen Delivery and Amplified Cancer Immunotherapy. ACS Nano. 2024;18(37):25826-25840. doi:10.1021/acsnano.4c09053

BibTeX
@article{Liu2024,
  author = {Liu, Jing and Cui, Yongsheng and Cabral, Horacio and Tong, Aiping and Yue, Qiang and Zhao, Lihong and Sun, Xun and Mi, Peng},
  title = {Glucosylated Nanovaccines for Dendritic Cell-Targeted Antigen Delivery and Amplified Cancer Immunotherapy},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {37},
  pages = {25826--25840},
  doi = {10.1021/acsnano.4c09053}
}
Kostenlos starten →